Former Senator Byron Dorgan (D-ND) wrote an opinion piece published in The Hill arguing that political posturing from a small segment of the petroleum industry has the Trump administration considering making changes to the renewable fuel standard.
Arent Fox partners D. Jacques Smith and Randall Brater and associate Michael Dearington penned an article published in the April issue of Pratt’s Government Contracting Law Report on the recent reversal of a substantial False Claims Act verdict.
Arent Fox Health Care Partner Linda Baumann discussed the potential compliance risks facing hospitals in connection with recalled medical devices for Bloomberg Law in an article titled, “Gaps in Hospital Recalled Device Reporting a ‘Wake-Up Call.’”
Complex Litigation Partner Dana Finberg recently spoke with Business Insurance on the subject of a US House of Representatives bill that aims to combat businesses’ vulnerabilities to “drive-by” Americans with Disabilities Act lawsuits.
Donna McPartland, Counsel in the Privacy, Cybersecurity & Data Protection practice, recently spoke with the American Bankers Association Banking Journal regarding their analysis of the upcoming data privacy regulation, the General Data Protection Regulation (GDPR).
On February 10, New York Partner Bernice Leber was quoted in an article by Bloomberg Law. The article discusses the lack of women as lead counsel in the courtroom and what steps can be taken to provide women lawyers with more opportunities to participate in leadership roles.
International Trade Practice Group Leader Kay Georgi, Counsel Regan Alberda, and Associate Lamine Hardaway discussed economic sanctions under President Donald Trump in an article for The Current: The Journal of the PLI Press.
Arent Fox Health Care partner and co-practice group leader Stephanie Trunk was nominated by corporate counsel to the 2018 Client Choice™ award list for the District of Columbia. Client Choice™ recognizes law firms and partners that stand apart for the excellent client service they provide.
FDA partner Georgia Ravitz and counsel Naomi Halpern discussed the withdrawal of Import Alert 66-38 in an article for Happi Magazine titled, “Anti-Aging Products Are Not Drugs! Does the withdrawal of Import Alert 66-38 signal a change of heart at the US Food and Drug Administration?”
Earlier this month, Partner Les Jacobowitz spoke with Reuters after the Virgin Islands Public Finance Authority filed an objection to Citigroup Inc.’s proposed $130 million settlement of a class action.
Senior director of regulatory policy Brian Ronholm recently analyzed the current debate over line speeds at poultry slaughter establishments in an opinion piece for Food Safety News titled, “Eschewing Obfuscation on Poultry Slaughter Line Speed.”
FDA counsel Brian Malkin discussed the recent language change in the internal FDA policy manual in an article published by Pink Sheet titled, “In Switching Generic 'Reviews' To 'Assessments' Is US FDA Changing More Than Just A Word?”
Bloomberg BNA’s Health Law Reporter provided an in-depth overview of the issues that likely will test health care lawyers in 2018 based on commentary from Bloomberg Law’s Health Care Advisory Board of which health care partner Lowell Brown is a member.
New York Partner Hunter Carter was quoted in an article published by Law360 regarding international arbitration trends to watch in 2018. Mr. Carter specifically spoke with Law360 about an increased focus on diversity in the field of international arbitration.
Senior Associate Frank Petrilli was recently featured by Law360 in an article about the new California laws effective in 2018 and how they will affect affordable housing and the California Environmental Quality Act, or CEQA.
Arent Fox Complex Litigation associate Michael Dearington recently published an article called “Ocasio v. United States: The Supreme Court’s Sudden Expansion of Conspiracy Liability (And Why Bribe-Taking Foreign Officials Should Take Note)” in the Washington & Lee Law Review Online.
The New York State Bar Association (NYSBA) has approved of the creation of a new Cannabis Law Committee, which will study and recommend measures—including legislation and administrative action—regarding a number of topics related to cannabis.
The Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against the state of California in response to the state’s new drug price law.
At Arent Fox, opportunity is a function of creativity, drive, and talent. You won’t find a top-down management structure setting the tone at our firm. Because we’re not a corporation, we’re a partnership. You’re in the driver’s seat. Let’s go.